Royal London removes need for HIV blood test in underwriting review

clock • 2 min read

Royal London has removed the need for an HIV blood test for non-medical limits (NMLs).

This used to be an automatic evidence requirement when underwriting large sum assured policies. The HIV test requirement was removed as incidence rates are reducing and survival rates have increased, the insurer said. This has been removed for all customers regardless of cover and sum assured and takes effect immediately.  Other amendments to non-medical limits evidence requirements and removal of financial evidence requirements for Personal Income Protection have been introduced.   However an HIV test will still be required where a customer discloses travel to certain regions, ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Beagle Street enters intermediary market

Beagle Street enters intermediary market

Life and CI

Cameron Roberts
clock 19 June 2026 • 3 min read
CIC claims for prostate cancer up by 65% since 2023: Aviva

CIC claims for prostate cancer up by 65% since 2023: Aviva

£38m paid out for prostate cancer in 2025

Jaskeet Briah
clock 15 June 2026 • 1 min read
Partner Insight: The evidence bottleneck - why claims slow down, and how we fix it together.

Partner Insight: The evidence bottleneck - why claims slow down, and how we fix it together.

Faster evidence. Clearer updates. Better support. Changes that could ease the bottleneck.

Dave Thompson, Senior claims technical manager, Scottish Widows
clock 15 June 2026 • 4 min read